Bayer

Whippany,  NJ 
United States
https://www.oncology.bayer.com
  • Booth: 5005a

Bayer is committed to delivering SCIENCE FOR A BETTER LIFE by advancing a portfolio of innovative treatments. We are focusing our research on potential first-in-class approaches across the areas of precision molecular oncology, targeted alpha therapies, and immuno-oncology. Bayer's oncology clinical trial information should not be construed as a recommendation for use of any unapproved compound or unapproved uses. If you have questions, we invite you to visit https://www.medinfo.bayer.com (for US HCPs) or https://globalvpir.bayer.com (for non-US HCPs).

Brands: https://events.jspargo.com/ASCO21/CUSTOM/Bayer%20Showcase%20Header_FINAL_1145x250.png


 Show Specials


 Press Releases


 Products

  • Bayer in Oncology
    Bayer is at the forefront of the evolving global oncology landscape. We have a patient-centered approach in all that we do and recognize the importance of bringing about innovation and change in oncology. Bayer’s research strategy is centered around meeting the needs of patients and making a meaningful difference to their lives through maximizing the utility of existing treatments as well as developing new ones. We are not doing this alone. World-leading research, pharmaceutical, advocacy and academic partners support us with this aspiration. Building on our heritage as an innovation driven company, we are continually advancing our approach and growing our differentiated portfolio with both internal and external efforts to meet the needs of patients where they are greatest. Together, we are paving the way in innovative science to advance care for patients....

  • Be persistent. Be Bayer.
    At Bayer, we’re visionaries driven to solve the world’s toughest challenges and striving for a world where our inclusive vision, health for all…hunger for none, is no longer a dream, but a real possibility. We’re doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining ‘impossible’. Twenty years ago, Bayer was starting research into what would become its very first cancer drug. Fast forward to today, we now have six cancer drugs on the market and several compounds in various stages of development that we hope will go on to benefit patients in the future. New research is vital to further our understanding of this complex disease and Bayer is fully committed and prepared researching new and targeted ways to treat cancer and improve patients’ lives. Building a sustainable culture of inclusion and diverse workforce are essential to our success. Be part of something bigger. Be a game changer. Be you. Be Bayer. You belong at Bayer!...